Our ongoing studies of the roles of IL-10 and/or nivolumab in regulating the function of other types of helper T cells such as regulatory T cells and other types of cells such as NK cells among others are an effort to shed more light on the roles and mechanisms of IL-10 in anti-cancer immune responses. Here, IL10 is linked to cancer.